Featured Article

Six geese a-laying: CluePoints’ AI predictions for 2026

Returning to the series is CluePoints, with Sophie Henderson, senior strategic consultant, sharing her hopes and expectations for how AI, analytics and risk-based approaches will continue to shape clinical development. From agentic AI to trust, transparency and smarter decision making, these predictions explore how the industry can turn technological potential into real-world impact in the year ahead.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Press Release
CluePoints and Tufts CSDD Publish Peer-Reviewed Evidence Quantifying the Financial Value of RBQM
Blog
The Hidden Inspection Risk in Your Medical and Safety Review Workflow
Blog
Why Medical and Safety Review Is One of the Last Manual Workflows in Clinical Trials